APA (7th ed.) Citation

Kubeczko, M., Polakiewicz-Gilowska, A., D’Amico, A., Chrabański, O., Świderska, K., Chmielik, E., . . . Jarząb, M. The role of FDG PET assessment in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 inhibitors in the second-line setting. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Kubeczko, Marcin, Anna Polakiewicz-Gilowska, Andrea D’Amico, Olgierd Chrabański, Katarzyna Świderska, Ewa Chmielik, Sławomir Blamek, Daria Handkiewicz-Junak, and Michał Jarząb. The Role of FDG PET Assessment in Patients with Advanced Breast Cancer Treated with Cyclin-dependent Kinase 4/6 Inhibitors in the Second-line Setting. Frontiers Media S.A.

MLA (9th ed.) Citation

Kubeczko, Marcin, et al. The Role of FDG PET Assessment in Patients with Advanced Breast Cancer Treated with Cyclin-dependent Kinase 4/6 Inhibitors in the Second-line Setting. Frontiers Media S.A.